You just read:

Sirnaomics Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for the Treatment of Primary Sclerosing Cholangitis (PSC)

News provided by

Sirnaomics, Inc.

Aug 01, 2017, 09:08 ET